|
|
| HCN1_HUMAN |
HCN1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 |
1.56e-52 |
0.31
|
| HCN4_HUMAN |
HCN4 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 |
2.14e-49 |
0.31
|
| I6X8D2_MYCTU |
pks13 |
Polyketide synthase Pks13 |
8.297e-37 |
0.29
|
| HCN2_HUMAN |
HCN2 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 |
1.332e-36 |
0.29
|
| HCN3_HUMAN |
HCN3 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 |
1.332e-36 |
0.29
|
| SSR5_HUMAN |
SSTR5 |
Somatostatin receptor type 5 |
9.5e-30 |
0.33
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
3.975e-27 |
0.32
|
| OGA_RAT |
Oga |
Protein O-GlcNAcase |
7.401e-26 |
0.29
|
| DCPS_HUMAN |
DCPS |
m7GpppX diphosphatase |
7.327e-24 |
0.34
|
| CCR8_HUMAN |
CCR8 |
C-C chemokine receptor type 8 |
3.411e-23 |
0.35
|
| SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
2.236e-11 |
0.35
|
| HIF1A_HUMAN |
HIF1A |
Hypoxia-inducible factor 1-alpha |
3.309e-11 |
0.35
|
| MBTP1_HUMAN |
MBTPS1 |
Membrane-bound transcription factor site-1 protease |
9.9e-11 |
0.29
|
| PARP1_MOUSE |
Parp1 |
Poly [ADP-ribose] polymerase 1 |
1.793e-10 |
0.32
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
2.399e-10 |
0.31
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
5.905e-10 |
0.31
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
1.481e-08 |
0.37
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
2.475e-08 |
0.32
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
7.099e-08 |
0.36
|
| PA2GA_HUMAN |
PLA2G2A |
Phospholipase A2, membrane associated |
6.069e-07 |
0.29
|
| NORA_STAAU |
norA |
Quinolone resistance protein NorA |
1.935e-06 |
0.32
|
| 5HT4R_RAT |
Htr4 |
5-hydroxytryptamine receptor 4 |
3.283e-06 |
0.34
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
7.829e-06 |
0.32
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
7.832e-06 |
0.39
|
| CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
8.279e-06 |
0.28
|